Compugen

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Compugen and other ETFs, options, and stocks.

About CGEN

Compugen Ltd. engages in the research, development, and commercialization of therapeutic and diagnostic biomarker product candidates including proteins and monoclonal antibodies. It focuses on research and development on immuno-oncology and autoimmune diseases.

CEO

Anat Cohen-Dayag

CEOAnat Cohen-Dayag

Employees

Employees74

Headquarters

Holon, Tel Aviv

HeadquartersHolon, Tel Aviv

Founded

1993

Founded1993

Employees

Employees74

CGEN Key Statistics

Market cap

137.46M

Market cap137.46M

Price-Earnings ratio

-9.45

Price-Earnings ratio-9.45

Dividend yield

—

Dividend yield—

Average volume

226.58K

Average volume226.58K

High today

$1.47

High today$1.47

Low today

$1.36

Low today$1.36

Open price

$1.37

Open price$1.37

Volume

170.40K

Volume170.40K

52 Week high

$2.66

52 Week high$2.66

52 Week low

$1.13

52 Week low$1.13

CGEN News

Simply Wall St 3d

Compugen First Quarter 2025 Earnings: Misses Expectations

Compugen ( ) First Quarter 2025 Results Key Financial Results Revenue: US$2.28m (down 11% from 1Q 2024). Net loss: US$7.18m (loss narrowed by 1.2% from 1Q 20...

People also own

Based on the portfolios of people who own CGEN. This list is generated using Robinhood data, and it’s not a recommendation.